secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001159036-26-000057
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme stockholders elect directors, approve say-on-pay, ratify auditor
-------------------------------------------------------------------------

- Directors Connaughton and Posard elected with 89.1M and 82.7M votes for, respectively.
- Advisory vote on executive compensation approved: 84.7M for, 9.3M against.
- Ratification of Ernst & Young as FY2026 auditor passed with 103.2M votes for.
- Over 104.1M of 118.5M outstanding shares were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903626000057/0001159036-26-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903626000057/halo-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001159036-26-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer